Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational studyDamiano Baroncini, Angelo Ghezzi, Antonio Bertolotto et al.|Multiple Sclerosis Journal|2018Cited by 62
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study)Francesco Patti, Diego Centonze, Clara Grazia Chisari et al.|Multiple Sclerosis and Related Disorders|2020Cited by 33
Relapse‐associated worsening in a real‐life multiple sclerosis cohort: the role of age and pyramidal phenotypeAurora Zanghì, Simonetta Galgani, Paolo Bellantonio et al.|European Journal of Neurology|2023Cited by 9
Multiple sclerosis from onset to secondary progression: a 30-year Italian register studyAurora Zanghì, Emanuele D’Amico, Massimiliano Copetti et al.|Journal of Neurology Neurosurgery & Psychiatry|2025Cited by 4
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered surveyManuela Altieri, Antonio Gallo, Rocco Capuano et al.|Multiple Sclerosis and Related Disorders|2023Cited by 2